Antitumor Effects of Hydromorphone on Human Gastric Cancer Cells in vitro [Retraction]
Liang B, Li C, Zhou Z, Xie Y. Drug Des Devel Ther. 2023;17:1037–1045. We, the Editor and Publisher of the journal Drug Design, Development and Therapy have retracted the published article. Following publication of the article, concerns were raised about the duplication of images from Figu...
Saved in:
Main Authors: | Liang B (Author), Li C (Author), Zhou Z (Author), Xie Y (Author) |
---|---|
Format: | Book |
Published: |
Dove Medical Press,
2024-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Antitumor Effects of Hydromorphone on Human Gastric Cancer Cells in vitro
by: Liang B, et al.
Published: (2023) -
Development of a Nanoliposomal Formulation of Erlotinib for Lung Cancer and in vitro/In vivo Antitumoral Evaluation [Retraction]
by: Zhou X, et al.
Published: (2022) -
Use of oral osmotic hydromorphone in opioid switch for cancer pain
by: Rosa Palomba, et al.
Published: (2008) -
Da0324, an inhibitor of nuclear factor-κB activation, demonstrates selective antitumor activity on human gastric cancer cells
by: Jin R, et al.
Published: (2016) -
Emodin enhances antitumor effect of paclitaxel on human non-small-cell lung cancer cells in vitro and in vivo
by: Chen S, et al.
Published: (2019)